{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":15,"n_cols":5,"rows_kept":15,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[13,2,13,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910463162103321"]
[null,null,"Autore",null,"Chapple Christopher"]
[null,null,"Titolo",null,"Contemporary Management of Overactive Bladder [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"London, : Future Medicine Ltd, 2013"]
[null,null,"ISBN",null,"1-78084-156-6"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (75 p.)"]
[null,null,"Disciplina",null,"616.62"]
[null,null,"Soggetti",null,"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Title page; Copyright page; Contents; Foreword. Contemporary management of overactive bladder; 1. Epidemiology of overactive bladder; 2. Lifestyle modifications for overactive bladder; 3. Antimuscarinic drugs for overactive bladder; 4. Devices; 5. Overactive bladder: guidelines; Index"]
[null,null,null,"Sommario/riassunto","The five chapters in this book provide a review of the epidemiology of overactive bladder and an overview of patient evaluation and the existing guidelines. The book addresses lifestyle modification (often ignored by clinicians), therapeutic options and current 'gold standard' pharmacotherapy (namely antimuscarinics)."]